Does CLOPIDOGREL BISULFATE Cause Product packaging quantity issue? 6 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Product packaging quantity issue have been filed in association with CLOPIDOGREL BISULFATE (Clopidogrel). This represents 0.0% of all adverse event reports for CLOPIDOGREL BISULFATE.
6
Reports of Product packaging quantity issue with CLOPIDOGREL BISULFATE
0.0%
of all CLOPIDOGREL BISULFATE reports
0
Deaths
1
Hospitalizations
How Dangerous Is Product packaging quantity issue From CLOPIDOGREL BISULFATE?
Of the 6 reports, 1 (16.7%) required hospitalization.
Is Product packaging quantity issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CLOPIDOGREL BISULFATE. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does CLOPIDOGREL BISULFATE Cause?
Gastrointestinal haemorrhage (5,513)
Anaemia (3,043)
Dyspnoea (1,963)
Drug interaction (1,846)
Haemorrhage (1,762)
Drug ineffective (1,644)
Cerebral haemorrhage (1,603)
Dizziness (1,586)
Epistaxis (1,560)
Melaena (1,547)
What Other Drugs Cause Product packaging quantity issue?
LEUPROLIDE (523)
ALBUTEROL (431)
BUDESONIDE\FORMOTEROL (301)
FENTANYL (286)
BUPRENORPHINE (225)
CYCLOSPORINE (206)
ESTRADIOL (201)
BIMATOPROST (177)
RIVAROXABAN (174)
EXENATIDE (154)
Which CLOPIDOGREL BISULFATE Alternatives Have Lower Product packaging quantity issue Risk?
CLOPIDOGREL BISULFATE vs CLORAZEPATE
CLOPIDOGREL BISULFATE vs CLOSTRIDIUM TETANI TOXOID ANTIGEN
CLOPIDOGREL BISULFATE vs CLOTHIAPINE
CLOPIDOGREL BISULFATE vs CLOTIAZEPAM
CLOPIDOGREL BISULFATE vs CLOTRIMAZOLE